232 related articles for article (PubMed ID: 16020262)
1. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
[TBL] [Abstract][Full Text] [Related]
3. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
Korte JM; Kaila T; Saari KM
Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
[TBL] [Abstract][Full Text] [Related]
4. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
Lee YH; Kompella UB; Lee VH
Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels and systemic safety of 0.1% unpreserved timolol maleate gel, 0.5% timolol aqueous solution and 0.5% timolol maleate gel.
Bonnin N; Nezzar H; Dubray C; Renault D; Olmiere C; Chiambaretta F
J Fr Ophtalmol; 2012 Jan; 35(1):9-16. PubMed ID: 21992993
[TBL] [Abstract][Full Text] [Related]
6. Timolol LA: a double-masked, active-controlled, randomized, crossover, comfort, ocular safety, and systemic bioavailability study in healthy volunteers.
Mundorf TK; Ogawa T; Inui N; Naka H; Novack GD; Crockett RS
Curr Med Res Opin; 2005 Mar; 21(3):369-74. PubMed ID: 15811205
[TBL] [Abstract][Full Text] [Related]
7. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects.
Nieminen T; Lehtimäki T; Mäenpää J; Ropo A; Uusitalo H; Kähönen M
Scand J Clin Lab Invest; 2007; 67(2):237-45. PubMed ID: 17366003
[TBL] [Abstract][Full Text] [Related]
8. Improvement of the ocular bioavailability of timolol by sorbic acid.
Higashiyama M; Inada K; Ohtori A; Tojo K
Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
[TBL] [Abstract][Full Text] [Related]
9. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
Ohdo S; Grass GM; Lee VH
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method.
Ohtori R; Sato H; Fukuda S; Ueda T; Koide R; Kanda Y; Kiuchi Y; Oguchi K
Exp Eye Res; 1998 Apr; 66(4):487-94. PubMed ID: 9593641
[TBL] [Abstract][Full Text] [Related]
11. Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily.
Shedden AH; Laurence J; Barrish A; Olah TV
Doc Ophthalmol; 2001 Jul; 103(1):73-9. PubMed ID: 11678162
[TBL] [Abstract][Full Text] [Related]
12. Effects of topical nipradilol and timolol maleate on intraocular pressure, facility of outflow, arterial blood pressure and pulse rate in dogs.
Maehara S; Ono K; Ito N; Tsuzuki K; Seno T; Yokoyama T; Yamashita K; Izumisawa Y; Kotani T
Vet Ophthalmol; 2004; 7(3):147-50. PubMed ID: 15091320
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of timolol and aceclidine after ocular instillation in the rabbit.
Matera MG; Lampa E; Imperatore A; Berrino L; Russo F; Boldrini E; Rossi F
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):35-42. PubMed ID: 9644717
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
Ishii Y; Nakamura K; Matsuki S; Uemura N; Muraguchi R; Nakagawa M; Nakano S; Nakatsuka K
J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
[TBL] [Abstract][Full Text] [Related]
15. [Influence on tear film after instillation of timolol maleate ophthalmic gel-forming solution examination by a tear film stability analysis system].
Kawasaki S; Mizoue S; Yamaguchi M; Ohashi Y
Nippon Ganka Gakkai Zasshi; 2008 Jun; 112(6):539-44. PubMed ID: 18592978
[TBL] [Abstract][Full Text] [Related]
16. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical timolol maleate on the ophthalmic artery blood pressure.
Grunwald JE; Furubayashi C
Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1095-100. PubMed ID: 2732023
[TBL] [Abstract][Full Text] [Related]
18. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.
Burgalassi S; Chetoni P; Panichi L; Boldrini E; Saettone MF
J Ocul Pharmacol Ther; 2000 Dec; 16(6):497-509. PubMed ID: 11132897
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
Lee VH; Luo AM; Li SY; Podder SK; Chang JS; Ohdo S; Grass GM
Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
[TBL] [Abstract][Full Text] [Related]
20. Respiratory and cardiovascular effects of WP-934 in guinea pigs.
Hashimoto T; Toyoda Y; Taniguchi T; Kitazawa Y
J Ocul Pharmacol Ther; 2001 Feb; 17(1):75-82. PubMed ID: 11322640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
